Analyst firms · H.C. Wainwright · BMEA

H.C. Wainwright BMEA price target and rating history

Biomea Fusion Inc. (BMEA) · Health Care

H.C. Wainwright rates Biomea Fusion Inc. (BMEA) Buy with a $44 price target, as of its latest action on Mar 28, 2023. It has published 3 rating actions on BMEA since January 2022, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$44
Median target, all firms
Too few
Actions on BMEA
3

H.C. Wainwright price target on BMEA

$44$29$132023202420252026
H.C. Wainwright price target on BMEA, each point a stated target, January 2022 to March 2023.

Every H.C. Wainwright rating on BMEA

Questions about H.C. Wainwright and BMEA

What is H.C. Wainwright's price target for BMEA?
H.C. Wainwright's latest stated price target for Biomea Fusion Inc. (BMEA) is $44, from its action on Mar 28, 2023.
What is H.C. Wainwright's rating on BMEA?
H.C. Wainwright rates BMEA Buy, a bullish rating, as of Mar 28, 2023.
When did H.C. Wainwright last change its view on BMEA?
On Mar 28, 2023, H.C. Wainwright raises its price target to $44 from $37, keeps Buy.

More BMEA rating histories

All H.C. Wainwright ratingsBMEA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.